首页> 外文会议>World biomaterials congress >In vitro Cellular and Molecular Mechanism of Osteoinductivity by Silicon Substituted Hydroxyapatite
【24h】

In vitro Cellular and Molecular Mechanism of Osteoinductivity by Silicon Substituted Hydroxyapatite

机译:硅取代羟基磷灰石的体外细胞和分子机制骨诱导性

获取原文

摘要

In conclusions silicon substituted hydroxyapatite was shown to enhance the bioactivity of hMSCs in vitro through its chemical composition irrespective of the influence of osteogenic supplements or surface morphology. The mechanism of osteoinduction involves the chemical composition of SiHA on expression of osteogenic marker genes and secretion of the osteogenic proteins. SiHA was shown to induce osteogenesis via early osteogenic differentiation of hMSCs as a result of the early termination of cell proliferation and early initiation of bone matrix mineralisation through increased expression of osteonectin gene and production of osteocalcin protein. Early expression of VEGF indicates the contribution of SiHA and HA to the promotion of early neo-vasculogenesis. In order to further evaluation of this biomaterial as an osteoinductive biomaterial, an in vivo study of bone formation by SiHA needs to be carried out.
机译:结论,显示硅取代的羟基磷灰石通过其化学组成而在体外增强HMSCs的生物活性,而与骨质发生补充剂或表面形态的影响无关。骨诱导机制涉及SiHA的化学成分对成骨标志物基因的表达和骨质发生蛋白的分泌。显示SiHa通过早期终止细胞增殖和早期骨基质矿化的早期终止,通过增加骨升素基因和骨科蛋白蛋白的产生,通过早期终止,通过HMSCs早期终止和早期开始的结果诱导骨发生。 VEGF的早期表达表明SIHA和HA对早期新血管发生的贡献。为了进一步评估这种生物材料作为骨诱导性生物材料,需要进行Siha对骨形成的体内研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号